Mohammad Sheibani1,2, Sadaf Nezamoleslami1,2, Hedyeh Faghir-Ghanesefat1,2, Amir Hossein Emami3, Ahmad Reza Dehpour4,5. 1. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, P.O. Box 13145-784, Tehran, Iran. 2. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran. 3. Hematology-Oncology Department, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran. 4. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, P.O. Box 13145-784, Tehran, Iran. dehpoura@tums.ac.ir. 5. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran. dehpoura@tums.ac.ir.
Abstract
PURPOSE: It has been supposed that cardiac toxicity of doxorubicin is due to its production of free radicals and inflammatory cytokines. Dapsone, an antibiotic drug which is the principal in a multidrug regimen for the treatment of leprosy, is a sulfone with anti-inflammatory and antioxidant immunosuppressive properties. Therefore, we designed this study to investigate the possible effects of dapsone on doxorubicin-induced cardiotoxicity. METHODS: Male rats were administrated doxorubicin (2.5 mg/kg) and dapsone (1, 3, 10 mg/kg) intraperitoneally six times in 2 weeks. Then electrocardiographic (ECG) parameters (QRS complexes, RR and QT intervals) alternation, papillary muscle contraction and excitation, and histopathological changes were assessed. Also, the heart tissue levels of malondialdehyde (MDA) as oxidant factor and superoxide dismutase (SOD) as antioxidant enzyme, tumor necrosis factor-alpha (TNF-α) and serum level of CK-MB were analyzed. RESULTS: Administration of dapsone with doxorubicin significantly reversed alterations induced by doxorubicin in serum levels of CK-MB, ECG parameters, papillary muscle contractility and excitation. Furthermore, the measurement of MDA, SOD and TNF-α tissue level indicated that dapsone significantly reduced oxidative stress and inflammation. These findings were consistent with histopathological analysis. CONCLUSION: Dapsone exerts cardioprotective effects on doxorubicin-induced cardiotoxicity through its anti-inflammatory and antioxidant mechanism.
PURPOSE: It has been supposed that cardiac toxicity of doxorubicin is due to its production of free radicals and inflammatory cytokines. Dapsone, an antibiotic drug which is the principal in a multidrug regimen for the treatment of leprosy, is a sulfone with anti-inflammatory and antioxidant immunosuppressive properties. Therefore, we designed this study to investigate the possible effects of dapsone on doxorubicin-induced cardiotoxicity. METHODS: Male rats were administrated doxorubicin (2.5 mg/kg) and dapsone (1, 3, 10 mg/kg) intraperitoneally six times in 2 weeks. Then electrocardiographic (ECG) parameters (QRS complexes, RR and QT intervals) alternation, papillary muscle contraction and excitation, and histopathological changes were assessed. Also, the heart tissue levels of malondialdehyde (MDA) as oxidant factor and superoxide dismutase (SOD) as antioxidant enzyme, tumor necrosis factor-alpha (TNF-α) and serum level of CK-MB were analyzed. RESULTS: Administration of dapsone with doxorubicin significantly reversed alterations induced by doxorubicin in serum levels of CK-MB, ECG parameters, papillary muscle contractility and excitation. Furthermore, the measurement of MDA, SOD and TNF-α tissue level indicated that dapsone significantly reduced oxidative stress and inflammation. These findings were consistent with histopathological analysis. CONCLUSION:Dapsone exerts cardioprotective effects on doxorubicin-induced cardiotoxicity through its anti-inflammatory and antioxidant mechanism.
Authors: Mina Khalilzadeh; Maryam Shayan; Sina Jourian; Mohammad Rahimi; Mohammad Sheibani; Ahmad Reza Dehpour Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2022-09-20 Impact factor: 3.195
Authors: Shama Mustafa; Muhammad Umar Ijaz; Qurat Ul Ain; Tayyaba Afsar; Ali Almajwal; Huma Shafique; Suhail Razak Journal: Toxicol Res (Camb) Date: 2022-05-23 Impact factor: 2.680
Authors: Walaa Yehia Abdelzaher; Sabreen Mahmoud Ahmed; Nermeen N Welson; Khalaf F Alsharif; Gaber El-Saber Batiha; Dina A Aly Labib Journal: Front Pharmacol Date: 2021-05-19 Impact factor: 5.810
Authors: Kalyani Tene; M Kalyan Kumar; G Basveshwar; P Eswara Rao; G Jagadeesh Kumar; Pramod Kumar; Deepak B Pemmaraju; U S N Murty; Ranadeep Gogoi; V G M Naidu Journal: Front Pharmacol Date: 2021-05-17 Impact factor: 5.810